Navigation Links
Watson Acquires Ascent Pharmahealth for AU$375 Million
Date:1/23/2012

PARSIPPANY, N.J., Jan. 24, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) announced that it has acquired Ascent Pharmahealth Ltd, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab Ltd, for AU$375 million in cash. As a result of the acquisition, Watson becomes the fifth largest generic pharmaceutical company in Australia based on revenue, and the combined company will be the second largest in terms of total molecules.  Watson also becomes the largest generics company in Singapore and gains an established commercial base in Malaysia, Hong Kong, Vietnam and Thailand. Watson expects the transaction to be immediately accretive to 2012 non-GAAP earnings.

Ascent markets a broad portfolio of generics, brands, branded-generic and over-the-counter (OTC) and dermatology and skin care products in Australia with approximately 14 percent market share. In the Southeast Asia market, Ascent markets branded-generics and OTC products, and is supported by a sales force of approximately 45 representatives.  The company employs approximately 300 employees in Australia and Southeast Asia.  Ascent's businesses in Australia and Southeast Asia had total sales of approximately AU$150 million in 2011.

"We are committed to expanding our international commercial operations into geographies where we can capitalize on our existing assets and participate in growing and emerging markets," said Paul Bisaro, Watson's President and CEO.  "This acquisition immediately establishes Watson among the leaders in the AU$12 billion Australian pharmaceutical market, where the generic market is growing at approximately 8 percent.  This acquisition complements our existing generic development and marketing capabilities in the important Australia market, and catapults us to a top five position that would have taken considerable time and inv
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
2. Watson to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
3. Watson Launches Generic LoSEASONIQUE(R)
4. Watson Launches Generic LIPITOR®
5. Watson to Present at the 2011 Piper Jaffray Health Care Conference
6. Watson Wins Kentucky Drug Pricing Litigation
7. Watson Confirms Exelon(R) Patent Challenge
8. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
9. Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
10. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
11. Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013  BioElectronics Corporation (OTC Pink: BIEL), the ... on the FDA panel meeting for non-thermal shortwave diathermy: ... Pulsed Shortwave Therapy Meeting was held on May 21, ... The focus of the meeting was very narrow, in ... solely on the application of non-thermal shortwave diathermy for ...
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of novel ... as primary biliary cirrhosis, today announced that ... Officer, will present at the Deutsche Bank Securities 38th ... on Wednesday, May 29, 2013 at 4:10 p.m. ...
(Date:5/23/2013)...  Inhibikase Therapeutics, Inc., an emerging leader in ... present new results on its antiviral program to ... the PML Consortium (composed of Pfizer, Bristol-Meyers Squibb, ... the causative agent of Progressive Multifocal Leukoencephalopathy (PML). ... extended release formulation, can clear JC polyomavirus (JCV) ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2
... Oct. 7 Nile Therapeutics, Inc. (Nasdaq: ... of novel therapeutics for cardiovascular disease, today announced that ... Advisory Board overseeing the development of CD-NP, a dual ... of acute decompensated heart failure. Dr. ...
... Reportlinker.com announces that a new market research report ... RIS/PACS Market http://www.reportlinker.com/p0306627/European-RIS/PACS-Market.html ... terms of the challenges faced by market participants, drivers ... the research service include an executive summary, overview of ...
Cached Medicine Technology:Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board 2Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board 3Reportlinker Adds European RIS/PACS Market 2Reportlinker Adds European RIS/PACS Market 3
(Date:5/23/2013)... Maintaining its commitment to improving life ... Campaign. Kicking off in the spirit of Better Sleep ... for everyone and to providing a therapeutic sleep experience, ... May is Better Sleep Month, a result of the ... due to the Centers for Disease Control’s confirmation that ...
(Date:5/23/2013)... To kick off barbecue season, fire up the grill this ... with simple tips from Retrofit weight loss . Keep ... , “The powerful heat of the grill can be one ... not mindful of your selections, it can be as bad ... Margulies. , Margulies advises clients to choose healthy options from ...
(Date:5/23/2013)... May 23, 2013 Retül University ... proud to announce the formation of a strategic educational ... Technologies to offer a bike industry first “Positioned ... aerodynamic assessment for time trial, road and triathlon bike ... offered to bike fitters with a Retül University, F.I.S.T. ...
(Date:5/23/2013)... to moderate iodine deficiency during pregnancy may have a ... report. Low levels of the so-called "trace element" ... child at risk of poorer verbal and reading skills ... women can boost their iodine levels by eating enough ... finding, published online May 22 in The Lancet ...
(Date:5/23/2013)... of support for war influences soldier PTSD , ... heightened risk for developing post-traumatic stress disorder if public ... recent research. Social validation or invalidation shapes the level ... the researchers say. The study involved two experiments that ... grinder in one, having an actor show either ...
Breaking Medicine News(10 mins):Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 2Health News:Fire It Up! Master Calories at the Grill with Retrofit Weight Loss 3Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 3Health News:Low Prenatal Iodine May Affect Child's Brain Development 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3
... could expose people to serious risks of injury and even death ... ,As lung cancer is the leading cause of cancer deaths among ... could save lives. But a study in New York seems to ... ,Dr. Peter B. Bach, a lung specialist and epidemiologist, who ...
... the number of amyloid plaques in the brains of ... like Alzheimer's. ,Roderic Eckenhoff, MD, Vice Chair ... Anesthesia and Critical Care, and his co-authors, report their ... of Aging. ,Every year over 100 million ...
... grow a genetically modified (GM) variety of rice from ... company behind the proposal, Ventria Bioscience, says the plants ... in infants. ,These plants, incorporating human genes ... some 3,000 acres (1,215 hectares) of farmland in the ...
... intake of soy isoflavones significantly reduced the risk of prostate ... cent//, says a new study. ,"To our knowledge, ... association between isoflavone and localized prostate cancer in Japanese, whose ... Kurahashi from Japan's National Cancer Center. ,Over half ...
... food industry representatives in Sydney has come out with the ... The move follows similar ones followed overseas by other food ... under pressure from the federal government to deal with the ... of trans fats in foods ,to be spelled out on ...
... faster than the current laboratory based detection, which may ... ,Sheila MacNeil and researchers at Sheffield University have ... bacteria in less then a minute by using light, ... ,The technology could have wide applications in wound healing, ...
Cached Medicine News:Health News:CT Scans may Not Benefit Lung Cancer Patients 2Health News:Inhaled Anesthetics Accelerate the Onset of Neurodegenerative Diseases Like Alzheimer's 2Health News:Soy Isoflavones Linked to Lower Prostate Cancer Risk 2
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Medicine Products: